113 related articles for article (PubMed ID: 10415944)
1. Imidazoline receptors and human brain disorders.
García-Sevilla JA; Escribá PV; Guimón J
Ann N Y Acad Sci; 1999 Jun; 881():392-409. PubMed ID: 10415944
[TBL] [Abstract][Full Text] [Related]
2. Dysregulation of IRAS/nischarin and other potential I
Keller B; García-Sevilla JA
J Affect Disord; 2017 Jan; 208():646-652. PubMed ID: 27836117
[TBL] [Abstract][Full Text] [Related]
3. Pharmacologic and molecular discrimination of I2-imidazoline receptor subtypes.
Olmos G; Alemany R; Boronat MA; García-Sevilla JA
Ann N Y Acad Sci; 1999 Jun; 881():144-60. PubMed ID: 10415910
[TBL] [Abstract][Full Text] [Related]
4. Immunodetection and quantitation of imidazoline receptor proteins in platelets of patients with major depression and in brains of suicide victims.
García-Sevilla JA; Escribá PV; Sastre M; Walzer C; Busquets X; Jaquet G; Reis DJ; Guimón J
Arch Gen Psychiatry; 1996 Sep; 53(9):803-10. PubMed ID: 8792757
[TBL] [Abstract][Full Text] [Related]
5. Pharmacologic characterization of imidazoline receptor proteins identified by immunologic techniques and other methods.
Escribá PV; Ozaita A; García-Sevilla JA
Ann N Y Acad Sci; 1999 Jun; 881():8-25. PubMed ID: 10415892
[TBL] [Abstract][Full Text] [Related]
6. The effects of phenelzine and other monoamine oxidase inhibitor antidepressants on brain and liver I2 imidazoline-preferring receptors.
Alemany R; Olmos G; García-Sevilla JA
Br J Pharmacol; 1995 Feb; 114(4):837-45. PubMed ID: 7773544
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the properties of agmatine and endogenous clonidine-displacing substance at imidazoline and alpha-2 adrenergic receptors.
Piletz JE; Chikkala DN; Ernsberger P
J Pharmacol Exp Ther; 1995 Feb; 272(2):581-7. PubMed ID: 7853171
[TBL] [Abstract][Full Text] [Related]
8. Platelet imidazoline receptors and regulatory G proteins in patients with major depression.
García-Sevilla JA; Escribá PV; Busquets X; Walzer C; Guimón J
Neuroreport; 1996 Dec; 8(1):169-72. PubMed ID: 9051774
[TBL] [Abstract][Full Text] [Related]
9. Immunodetection and subcellular distribution of imidazoline receptor proteins with three antibodies in mouse and human brains: Effects of treatments with I1- and I2-imidazoline drugs.
Keller B; García-Sevilla JA
J Psychopharmacol; 2015 Sep; 29(9):996-1012. PubMed ID: 26038110
[TBL] [Abstract][Full Text] [Related]
10. Platelet I1-imidazoline binding sites are elevated in depression but not generalized anxiety disorder.
Piletz JE; Halaris A; Nelson J; Qu Y; Bari M
J Psychiatr Res; 1996; 30(3):147-68. PubMed ID: 8884655
[TBL] [Abstract][Full Text] [Related]
11. Nonadrenergic imidazoline binding sites on human platelets.
Piletz JE; Sletten K
J Pharmacol Exp Ther; 1993 Dec; 267(3):1493-502. PubMed ID: 8263811
[TBL] [Abstract][Full Text] [Related]
12. Characterisation of imidazoline I2 binding sites in pig brain.
Anderson NJ; Lupo PA; Nutt DJ; Hudson AL; Robinson ES
Eur J Pharmacol; 2005 Sep; 519(1-2):68-74. PubMed ID: 16109401
[TBL] [Abstract][Full Text] [Related]
13. Discrimination and pharmacological characterization of I2-imidazoline sites with [3H]idazoxan and alpha-2 adrenoceptors with [3H]RX821002 (2-methoxy idazoxan) in the human and rat brains.
Miralles A; Olmos G; Sastre M; Barturen F; Martin I; Garcia-Sevilla JA
J Pharmacol Exp Ther; 1993 Mar; 264(3):1187-97. PubMed ID: 8095548
[TBL] [Abstract][Full Text] [Related]
14. Imidazoline receptor proteins are decreased in the hippocampus of individuals with major depression.
Piletz JE; Zhu H; Ordway G; Stockmeier C; Dilly G; Reis D; Halaris A
Biol Psychiatry; 2000 Nov; 48(9):910-9. PubMed ID: 11074229
[TBL] [Abstract][Full Text] [Related]
15. Identification and characterization of platelet α2-adrenoceptors and imidazoline receptors in rats, rabbits, cats, dogs, cattle, and horses.
Hikasa Y; Masuda K; Asakura Y; Yamashita Y; Sato C; Kamio M; Miura A; Taniguchi T; Minamizuru N
Eur J Pharmacol; 2013 Nov; 720(1-3):363-75. PubMed ID: 24120658
[TBL] [Abstract][Full Text] [Related]
16. Imidazoline binding sites in human placenta: evidence for heterogeneity and a search for physiological function.
Diamant S; Eldar-Geva T; Atlas D
Br J Pharmacol; 1992 May; 106(1):101-8. PubMed ID: 1324063
[TBL] [Abstract][Full Text] [Related]
17. Comparison of ligand binding affinities at human I1-imidazoline binding sites and the high affinity state of alpha-2 adrenoceptor subtypes.
Piletz JE; Zhu H; Chikkala DN
J Pharmacol Exp Ther; 1996 Nov; 279(2):694-702. PubMed ID: 8930173
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological modulation of immunoreactive imidazoline receptor proteins in rat brain: relationship with non-adrenoceptor [3H]-idazoxan binding sites.
Escribá PV; Alemany R; Sastre M; Olmos G; Ozaita A; García-Sevilla JA
Br J Pharmacol; 1996 Aug; 118(8):2029-36. PubMed ID: 8864539
[TBL] [Abstract][Full Text] [Related]
19. Decreased density of I2-imidazoline receptors in the postmortem brain of heroin addicts.
Sastre M; Ventayol P; García-Sevilla JA
Neuroreport; 1996 Jan; 7(2):509-12. PubMed ID: 8730817
[TBL] [Abstract][Full Text] [Related]
20. I1-imidazoline receptors. Definition, characterization, distribution, and transmembrane signaling.
Ernsberger P; Graves ME; Graff LM; Zakieh N; Nguyen P; Collins LA; Westbrooks KL; Johnson GG
Ann N Y Acad Sci; 1995 Jul; 763():22-42. PubMed ID: 7677333
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
